Fujian Wanchen Biotechnology Co. Ltd Cash Flow-to-Debt Ratio
Fujian Wanchen Biotechnology Co. Ltd cash flow-to-debt ratio. Fujian Wanchen Biotechnology Co. Ltd (300972) has a Cash Flow-to-Debt Ratio of 0.48x as of December 2025, meaning its operating cash flow of CN¥3.63 Billion could theoretically repay 0% of its total liabilities (CN¥7.50 Billion) in one year. Check Fujian Wanchen Biotechnology Co. Ltd cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Fujian Wanchen Biotechnology Co. Ltd (2019–2025)
Cash flow-to-debt ratio of Fujian Wanchen Biotechnology Co. Ltd from 2019 to 2025. Historical debt coverage capacity for Fujian Wanchen Biotechnology Co. Ltd across 7 annual periods. Check Fujian Wanchen Biotechnology Co. Ltd total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Fujian Wanchen Biotechnology Co. Ltd Cash Flow-to-Debt Ratio by Year (2019–2025)
Fujian Wanchen Biotechnology Co. Ltd cash flow-to-debt ratio by year from 2019 to 2025. Year-by-year debt coverage analysis for Fujian Wanchen Biotechnology Co. Ltd. For the full cash flow conversion analysis, see Fujian Wanchen Biotechnology Co. Ltd cash flow conversion.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.48x | CN¥3.63 Billion | CN¥7.50 Billion | ▲ +230.7% |
| 2024 | 0.15x | CN¥848.35 Million | CN¥5.79 Billion | ▼ -53.8% |
| 2023 | 0.32x | CN¥1.02 Billion | CN¥3.23 Billion | ▲ +138.0% |
| 2022 | 0.13x | CN¥70.38 Million | CN¥528.79 Million | ▼ -71.7% |
| 2021 | 0.47x | CN¥98.82 Million | CN¥210.47 Million | ▼ -22.5% |
| 2020 | 0.61x | CN¥156.24 Million | CN¥257.94 Million | ▲ +6.2% |
| 2019 | 0.57x | CN¥177.28 Million | CN¥310.81 Million | — |